Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 403 M454.9 M368.1 M — Research & development ——— — Operating income 39.5 M-34.7 M64.9 M — Non-Operating Income, Total 67 M-18.4 M4.4 M — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 63.9 M-17.7 M8.1 M — Unusual income/expense 3.1 M-700 K-3.7 M — Pretax income 11.6 M-162.7 M-10.2 M — Equity in earnings 1.1 M600 K800 K — Taxes 23.8 M34.2 M54.2 M — Non-controlling/minority interest 1.9 M1.7 M2.5 M — After tax other income/expense ——— — Net income before discontinued operations -14.1 M-198.6 M-66.9 M — Discontinued operations 000 — Net income -14.1 M-198.6 M-66.9 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -14.1 M-198.6 M-66.9 M — Basic earnings per share (Basic EPS) -140 K-0.7880 K — Diluted earnings per share (Diluted EPS) -140 K-0.7-0.25 — Average basic shares outstanding 100281.96 M266.92 M — Diluted shares outstanding 100281.96 M266.92 M — EBITDA 193.3 M132.2 M228.2 M — EBIT 39.5 M-34.7 M64.9 M — Cost of revenue 449.2 M466.9 M515.2 M — Other cost of goods sold 449.2 M466.9 M515.2 M — Depreciation & amortization (cash flow) 153.8 M166.9 M163.3 M —